InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Ben Yong. Director active across 2 companies, notably Corbus Pharmaceuticals Holdings, Inc.. Aggregated, 5 filings have been logged. Activity tracked since 30 May 2024. The latest transaction was disclosed on 1 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Ben Yong is a declarant linked to Corbus Pharmaceuticals Holdings, Inc., where he is Director, and to BridgeBio Oncology Therapeutics, Inc., where he is Chief Med & Dev Officer. He has 5 filings in total, and across the 5 recent filings observed, the period runs from 2024-06-03 to 2026-07-06, with the transaction nature shown as Attribution.